Clinical Trials Browser

Phase 1/2 × ixazomib × 30 days × Clear all

NCT04094961 2026-03-05

Ixazomib + Pomalidomide + Dexamethasone In MM

Phase 1/2 Active not recruiting

Multiple Myeloma